NO20055536D0 - Fremgangsmate for forbedret diurese i individer med svekket nyrefunksjon - Google Patents

Fremgangsmate for forbedret diurese i individer med svekket nyrefunksjon

Info

Publication number
NO20055536D0
NO20055536D0 NO20055536A NO20055536A NO20055536D0 NO 20055536 D0 NO20055536 D0 NO 20055536D0 NO 20055536 A NO20055536 A NO 20055536A NO 20055536 A NO20055536 A NO 20055536A NO 20055536 D0 NO20055536 D0 NO 20055536D0
Authority
NO
Norway
Prior art keywords
individuals
procedures
renal function
impaired renal
diuresis
Prior art date
Application number
NO20055536A
Other languages
English (en)
Other versions
NO20055536L (no
Inventor
Kenneth J Widder
Lauren Otsuki
Howard Dittrich
Scott Thomson
Roland Blantz
Original Assignee
Novacardia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacardia Inc filed Critical Novacardia Inc
Publication of NO20055536D0 publication Critical patent/NO20055536D0/no
Publication of NO20055536L publication Critical patent/NO20055536L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
NO20055536A 2003-04-25 2005-11-23 Fremgangsmate for forbedret diurese i individer med svekket nyrefunksjon NO20055536L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46600703P 2003-04-25 2003-04-25
PCT/US2004/012518 WO2004096228A1 (en) 2003-04-25 2004-04-23 Method of improved diuresis in individuals with impaired renal function

Publications (2)

Publication Number Publication Date
NO20055536D0 true NO20055536D0 (no) 2005-11-23
NO20055536L NO20055536L (no) 2005-12-29

Family

ID=33418325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055536A NO20055536L (no) 2003-04-25 2005-11-23 Fremgangsmate for forbedret diurese i individer med svekket nyrefunksjon

Country Status (16)

Country Link
US (3) US7579331B2 (no)
EP (1) EP1620107A1 (no)
JP (1) JP2006524699A (no)
KR (1) KR20060004959A (no)
CN (1) CN1859913A (no)
AR (1) AR044069A1 (no)
AU (1) AU2004233852A1 (no)
BR (1) BRPI0409699A (no)
CA (1) CA2522971A1 (no)
MX (1) MXPA05011371A (no)
NO (1) NO20055536L (no)
NZ (1) NZ543109A (no)
RU (1) RU2367442C2 (no)
TW (1) TW200500070A (no)
WO (1) WO2004096228A1 (no)
ZA (1) ZA200509311B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
NZ543109A (en) * 2003-04-25 2008-06-30 Novacardia Inc Method of improved diuresis in individuals with impaired renal function
US20060293312A1 (en) * 2003-04-25 2006-12-28 Howard Dittrich Method of improved diuresis in individuals with impaired renal function
JP2007504136A (ja) * 2003-08-28 2007-03-01 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
BRPI0509753A (pt) * 2004-04-16 2007-10-16 Novacardia Inc composição farmacêutica e método de tratamento de doença cardiovascular
CA2597460A1 (en) * 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
JP2008536919A (ja) * 2005-04-22 2008-09-11 ノヴァカーディア，インク． 医薬組成物のエマルションの製造
AU2006325984A1 (en) * 2005-12-14 2007-06-21 Kyowa Hakko Kirin Co., Ltd. Easily absorbed oral preparation containing xanthine derivative
WO2007117549A2 (en) * 2006-04-06 2007-10-18 Novacardia, Inc. Co-administration of adenosine a1 receptor antagonists and anticonvulsants
EP2035009A1 (en) * 2006-06-16 2009-03-18 Novacardia, Inc. Prolonged improvement of renal function comprising infrequent administration of an aa1ra
EP2035092A2 (en) * 2006-06-16 2009-03-18 Novacardia, Inc. Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload
US20090197900A1 (en) * 2007-03-29 2009-08-06 Howard Dittrich Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist
US20080242684A1 (en) * 2007-03-29 2008-10-02 Howard Dittrich Methods of administration of adenosine a1 receptor antagonists

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416810C (sv) 1977-10-14 1982-05-11 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
FR2531085A1 (fr) 1982-07-28 1984-02-03 Adir Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4769377A (en) * 1983-02-18 1988-09-06 The Johns Hopkins University Adenosine receptor antagonists
DE8817122U1 (no) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 6507 Ingelheim, De
US5290782A (en) * 1989-09-01 1994-03-01 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
SE9000207L (sv) 1990-01-22 1991-07-23 Nobel Chemicals Ab Laekemedel samt anvaendningen av detsamma
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
WO1993000081A1 (en) 1991-06-28 1993-01-07 Sepracor, Inc. Optically pure s(-) nadolol for treatment of cardiovascular disorders
CA2093403C (en) 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
TW252044B (no) 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
DE4238367A1 (de) * 1992-11-13 1994-05-19 Boehringer Ingelheim Kg Diuretisches Mittel
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
CN1049117C (zh) 1994-09-16 2000-02-09 赵明玉 预防和治疗偏头痛的偏头痛片
ATE240734T1 (de) * 1995-07-26 2003-06-15 Kyowa Hakko Kogyo Kk Zubereitung von xanthinderivaten als feste dispersion
EP0958821B1 (en) 1996-08-07 2004-11-10 Kyowa Hakko Kogyo Co., Ltd. Fat emulsion containing xanthine derivative
DE19816857A1 (de) 1998-04-16 1999-10-21 Boehringer Ingelheim Pharma Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6187780B1 (en) * 1998-04-16 2001-02-13 Boehringer Ingelheim Pharma Kg Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity
US20020115687A1 (en) 1998-04-24 2002-08-22 Evan Beckman Method and composition for restoring diuretic and renal function
AU3757999A (en) * 1998-04-24 1999-11-16 Biogen, Inc. Adenosine a1 receptor antagonist containing composition and method for restoringdiuretic and renal function
EP0970696A1 (en) 1998-05-05 2000-01-12 Kyowa Hakko Kogyo Co., Ltd. Combination of loop diuretics with adenosine A1-receptor antagonists
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
MEP42208A (en) * 1999-11-12 2011-02-10 Biogen Idec Inc Polycycloalkylpurines as adenosine receptor antagonists
WO2001034604A2 (en) 1999-11-12 2001-05-17 Biogen, Inc. Adenosine receptor antagonists and methods of making and using the same
US20050038017A1 (en) * 1999-12-22 2005-02-17 Wolff Andrew A. Method and composition for restoring diuretic and renal function
AU2002219977B2 (en) * 2000-12-01 2008-01-24 Biogen Idec Ma Inc. Condensed purine derivatives as A1 adenosine receptor antagonists
WO2002049645A1 (en) 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
US20060293312A1 (en) * 2003-04-25 2006-12-28 Howard Dittrich Method of improved diuresis in individuals with impaired renal function
NZ543109A (en) * 2003-04-25 2008-06-30 Novacardia Inc Method of improved diuresis in individuals with impaired renal function
WO2005000294A1 (en) * 2003-06-06 2005-01-06 Pharmacia Corporation Selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
BRPI0509753A (pt) * 2004-04-16 2007-10-16 Novacardia Inc composição farmacêutica e método de tratamento de doença cardiovascular
EP1751159A2 (en) * 2004-04-28 2007-02-14 Cv Therapeutics, Inc. Purine derivatives as a1 adenosine receptor antagonists
WO2007117549A2 (en) 2006-04-06 2007-10-18 Novacardia, Inc. Co-administration of adenosine a1 receptor antagonists and anticonvulsants
EP2035092A2 (en) * 2006-06-16 2009-03-18 Novacardia, Inc. Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload
EP2035009A1 (en) * 2006-06-16 2009-03-18 Novacardia, Inc. Prolonged improvement of renal function comprising infrequent administration of an aa1ra
JP2010501557A (ja) * 2006-08-22 2010-01-21 ノヴァカーディア，インク． 血液脳関門を通過しないｋｗ−３９０２コンジュゲート

Also Published As

Publication number Publication date
TW200500070A (en) 2005-01-01
NZ543109A (en) 2008-06-30
US20060035911A1 (en) 2006-02-16
CN1859913A (zh) 2006-11-08
AU2004233852A1 (en) 2004-11-11
EP1620107A1 (en) 2006-02-01
KR20060004959A (ko) 2006-01-16
US20060030572A1 (en) 2006-02-09
WO2004096228A1 (en) 2004-11-11
US20050004145A1 (en) 2005-01-06
RU2005131938A (ru) 2006-06-27
JP2006524699A (ja) 2006-11-02
BRPI0409699A (pt) 2006-04-18
CA2522971A1 (en) 2004-11-11
MXPA05011371A (es) 2005-12-01
NO20055536L (no) 2005-12-29
US7579331B2 (en) 2009-08-25
ZA200509311B (en) 2006-10-25
AR044069A1 (es) 2005-08-24
RU2367442C2 (ru) 2009-09-20

Similar Documents

Publication Publication Date Title
NO20055536D0 (no) Fremgangsmate for forbedret diurese i individer med svekket nyrefunksjon
FR2868881B1 (fr) Titre en anglais
DE60336044D1 (de) Sitzgleitschiene
DK1343007T3 (da) Elektrokemisk sensor
NO20034167D0 (no) Vippeanordning i forbindelse med multifunksjonelle brytere
PT1513836E (pt) Derivados de piperazinilacilpiperidina, sua preparacao e sua aplicacao em terapeutica
DK1615536T3 (da) Forbedringer i sanitære ruller
NO20054199D0 (no) 6-substituerte imidazopyraziner
DE60328921D1 (de) Kondom mit integriertem wulstaufbau
DE602004008368D1 (de) Kaschiermaschine
BRMU8400954Y1 (pt) disposiÇço em limpador de lÍngua.
FR2870577B1 (fr) Element d'absorption
DE60316553D1 (de) Verbinder
ATA13202003A (de) Sitzmöbel
DE602004008143D1 (de) Kaschiermaschine
DE10392685D2 (de) Sitzmöbel
FR2878735B1 (fr) Civiere a geometrie variable, helitreuillable, flottante destinee notamment a la recuperation de personnes.
ATE491849T1 (de) Verbund
FI6341U1 (fi) Sovitelma porakaivon yhteydessä
FI20021353A0 (fi) Istuin
DE502004001835D1 (de) Abfallsammler
FI20041678A0 (fi) Takaperoinen tasku
FI20045499A0 (fi) Järjestely oskillointilaitteessa
ITVI20030127A1 (it) Solaio in latero - cemento.
ITGE20040086A1 (it) Valvole in sincronia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application